{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:56Z","timestamp":1786119536930,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/wnf.0b013e3181ebb285","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T04:21:11Z","timestamp":1278562871000},"page":"260-264","source":"Crossref","is-referenced-by-count":66,"title":["Efficacy and Safety of the Dopaminergic Stabilizer Pridopidine (ACR16) in Patients With Huntington's Disease"],"prefix":"10.1097","volume":"33","author":[{"given":"Anders","family":"Lundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Espen","family":"Dietrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise","family":"G\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Heiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Loutfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Widner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas","family":"Wiktorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clas","family":"Sonesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Tedroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00019052-200008000-00013","article-title":"Recent advances in Huntington's disease.","volume":"13","author":"Gutekunst","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease.","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"R4-11-20210203","first-page":"219","article-title":"Behavioral changes in Huntington's disease.","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R6-11-20210203","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2174\/138161206777698693","article-title":"Pharmacological management of Huntington's disease: an evidence-based review.","volume":"12","author":"Bonelli","year":"2006","journal-title":"Curr Pharm Des"},{"key":"R7-11-20210203","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1124\/jpet.106.102905","article-title":"The dopamine stabilizers (S)-()-(3-methanesulfonyl-phenyl)-1-propyl-piperidine ()-OSU6162 and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for motor side effects in the rat.","volume":"318","author":"Natesan","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"R9-11-20210203","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.pnpbp.2004.05.004","article-title":"The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.","volume":"28","author":"Nilsson","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R12-11-20210203","first-page":"83","article-title":"The Symbol Digit Modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders.","volume":"3","author":"Smith","year":"1968","journal-title":"Learn Disord"},{"key":"R13-11-20210203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency.","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"R14-11-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indication of organic brain damage.","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"R15-11-20210203","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S0033291700014379","article-title":"Factor analysis of a sleep evaluation questionnaire.","volume":"8","author":"Parrott","year":"1978","journal-title":"Psychol Med"},{"key":"R16-11-20210203","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"R19-11-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jnnp.63.1.35","article-title":"Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.","volume":"63","author":"van Vugt","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-11-20210203","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/01.WNL.0000086373.32347.16","article-title":"Huntington's disease: clinical correlates of disability and progression.","volume":"61","author":"Mahant","year":"2003","journal-title":"Neurology"},{"key":"R21-11-20210203","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ana.10691","article-title":"Predictors of neuropathological severity in 100 patients with Huntington's disease.","volume":"54","author":"Rosenblatt","year":"2003","journal-title":"Ann Neurol"},{"key":"R22-11-20210203","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mds.870110406","article-title":"Hypokinesia in Huntington's disease.","volume":"11","author":"van Vugt","year":"1996","journal-title":"Mov Disord"},{"key":"R23-11-20210203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archneur.1996.00550060035012","article-title":"Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.","volume":"53","author":"Zappacosta","year":"1996","journal-title":"Arch Neurol"},{"key":"R24-11-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/0894-4105.21.1.31","article-title":"Early cognitive deficits in Swedish gene carriers of Huntington's disease.","volume":"21","author":"Robins Wahlin","year":"2007","journal-title":"Neuropsychology"},{"key":"R25-11-20210203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1467-9450.00238","article-title":"Dopamine and cognitive functioning: brain imaging findings in Huntington's disease and normal aging.","volume":"42","author":"Backman","year":"2001","journal-title":"Scand J Psychol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181ebb285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:30:24Z","timestamp":1786041024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201009000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181ebb285","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}